Broadfin Capital LLC 13D and 13G filings for Eiger BioPharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-01-04 11:29 am Sale | 2021-01-04 | 13G | Eiger BioPharmaceuticals, Inc. EIGR | Broadfin Capital LLC | 0 0.000% | -41,212 (Position Closed) | Filing |